Article Details

Canaccord Genuity Raises Meridian Bioscience (NASDAQ:VIVO) Price Target to $16.00

Retrieved on: 2018-02-21 09:18:45

Tags for this article:

Click the tags to see associated articles and topics

Canaccord Genuity Raises Meridian Bioscience (NASDAQ:VIVO) Price Target to $16.00. View article details on HISWAI:

Excerpt

<div><b>Millennium Management</b> LLC lifted its holdings in Meridian Bioscience by 55.0% in the fourth quarter. <b>Millennium Management</b> LLC now owns 1,133,765 shares of the company's stock valued at $15,873,000 after acquiring an additional 402,430 shares during the period. SG Capital Management LLC ...</div>

Article found on:

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up